New Delhi: Revised maximum retail prices for 1,364 anti-cancer formulations came into effect on November 9. The National Pharmaceutical Pricing Authority (NPPA) expects the changes to save consumers ₹3,540.38 crore annually.
The NPPA operates under the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers. It capped trade margins on the MRP of 137 anti-cancer drugs. The decision followed recommendations from an Expert Committee constituted by the Directorate General of Health Services on October 17, 2026.
As of November 8, 85 pharmaceutical companies had reported revised prices for 1,364 formulations covering 121 drugs. Among these, 679 brands reported price reductions exceeding 50%. The highest reported reduction in MRP was 96.45%.
The revised prices apply from November 9, 2026. The estimated annual savings reflect the expected impact of these reductions on medicine costs for consumers. The reported figures cover formulations across the participating pharmaceutical companies.
Anti-cancer formulations: How consumers can check revised prices
Consumers can check the updated MRP printed on medicine packs before making purchases. They can also verify prices through the Pharma Sahi Daam mobile application or the NPPA website at nppa.gov.in.
Chemists and hospital pharmacies cannot charge more than the revised MRP. Therefore, consumers should compare the price charged with the MRP printed on the pack. This helps them identify any overcharging at the point of purchase.
Consumers can register pricing-related grievances through the Pharma Jan Samadhan portal. They can also contact the NPPA helpline at 1800-111-255. These channels provide options for reporting violations and seeking action on complaints.
The revised prices apply to the listed anti-cancer formulations from November 9. Consumers should check the specific medicine pack for its updated MRP. The NPPA has also made price verification available through its mobile application and website.
